Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Agribusiness and Applied Economics at North Dakota State University.
Public Health Bureaucracies Consolidate Power as Pandemic Continues


In a surprising memo released last month by Secretary of Health and Human Services Alex Azar, federal agencies under the umbrella of his department are now prohibited from passing additional regulations on food, medicines, medical devices, and vaccines without Azar’s approval. As stated in the memo, “Any prior delegation of rulemaking authority, including the...
Read More »

Economic Miscalculation and the Covid-19 Pandemic


As Covid-19 began to spread through the United States in February, many feared hospitals would become overwhelmed with infected patients. To meet the demands a global pandemic places on our healthcare system, the U.S. Army Corps of Engineers began hiring private contractors to build field hospitals to treat patients when hospitals hit capacity. The...
Read More »

FDA Approves Blood Plasma as Covid-19 Treatment


In the nearly eight months since Covid-19 arrived in the United States, the country has undergone extensive lockdowns, trying economic hardship, and prolonged social isolation. Despite these sacrifices to battle the pandemic, the U.S. continues to lead the world in total confirmed Covid-19 cases and Covid-19 fatalities. As of September 9, the Coronavirus Resource...
Read More »

Promising Alzheimer’s Drug on FDA Fast Track


Well before Covid-19 emerged, medical researchers warned that the rapid increase of Alzheimer’s disease in older populations would lead to the next “pandemic.” In many respects, they were right. According to the Alzheimer’s Association, nearly 10 percent of the U.S. population over 65 years old suffers from that progressively destructive brain disorder. The same...
Read More »

Is the Covid-19 Pandemic Spreading Affinity for Socialism? It Shouldn’t!


Famed Economist Thomas Sowell has long remarked that “Socialism in general has a record of failure so blatant that only an intellectual could ignore or evade it.” He might need to add Millennials to this paltry list. A recent Bloomberg opinion column by Andreas Kluth argues that the economic hardships stemming from the Covid-19...
Read More »

Trump Signs More Executive Orders as a Last-Ditch Effort to Lower Drug Prices


It has been over three years since Donald Trump became the 45th President of the United States of America. During his first run for the Oval Office, he vowed to take on drug companies and lower the cost of prescription drugs. With less than one-hundred days until the 2020 presidential election, he has yet...
Read More »

State Mismanagement of Covid-19 Data Continues


Mindy Clark of Sarasota, Florida, drove to a COVID-19 testing site at Manatee Rural Health because she thought she might have contracted the virus. At the drive-thru testing center, she was told to take the test only if she had experienced symptoms. She drove away before being swabbed. Two days later, she received a...
Read More »

Don’t Trust Government to Distribute Covid-19 Drugs


As new Covid-19 cases continue across the U.S., many states are preparing for a potential second wave of outbreaks and reinstated lockdown measures. Arizona hospitals are enacting emergency plans to accommodate a rapid influx of new infections. Florida has ordered bars to stop serving alcohol (after allowing them to reopen less than a month...
Read More »

President Trump’s ‘Operation Warp Speed’ Vaccine Project Might Crash Into Perverse Incentives


This May, President Trump unveiled Operation Warp Speed, a partnership between federal regulatory agencies and private drug producers that aims to develop and distribute a Covid-19 vaccine by January. The president described the project’s lofty goal of achieving a pioneering scientific discovery in record-breaking time as “unlike anything our country has seen since The Manhattan...
Read More »

To Make Drugs More Affordable, President Trump Should Focus on Price Competition


President Trump has tried seemingly everything to lower prescription drug prices. In 2018 alone, he established an international pricing index to prevent overcharging from foreign drug producers, targeted drug rebates between producers and middlemen, and granted Medicare Part D plans more authority to negotiate drug prices. Despite these and other efforts, the prices for thousands of...
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org